Objective: Osteoarthritis is a disease process of cellular degradation of articular cartilage caused by mechanical loads and inflammatory cytokines. We studied the cellular response in native cartilage subjected to a mechanical load administered simultaneously with an inflammatory cytokine interleukin-1 (IL-1), hypothesizing that the combination of load and cytokine would result in accelerated extracellular matrix (ECM) degradation.
Introduction
Osteoarthritis (OA) is a pathological condition of articular cartilage associated with extracellular matrix (ECM) degradation related to mechanical (wear-and-tear, high stress, trauma) and inflammatory (physicochemical) mechanisms, both of which have been shown to increase enzyme synthesis by chondfrocytes . Each cleavage site produces a unique neoepitope which can be recognized by specific antibodies. Several studies have hypothesized that aggrecanase is the primary enzyme responsible for aggrecan proteolysis in the early stages of cartilage degeneration, well before aggrecan and collagen cleavage by MMPs 2, 3, 7 . These studies used physiochemically induced models of OA in which Interleukin-1 (IL-1) was used to stimulate a catabolic response by the chondrocytes. While the inflammatory-induced injury model of OA has been well characterized, the mechanically induced injury model of OA is not.
Several mechanically induced in-vitro cell and tissue injury models have reported increased synthesis of MMPs and ECM degradation while one study found increased aggrecanase but only at the messenger level 4,8e15 . Recent evidence indicates that the mechanical and inflammatory mechanisms may be synergistic, resulting in a mechanically induced down-regulation of the cellular catabolic response caused by IL-1 stimulation 16e21 . Thus, a mechanical load appears to inhibit the cleavage of aggrecan induced by IL-1 stimulation. Based on previous investigations 4, 12, 22 , we hypothesized that different magnitudes of load applied in the presence of an inflammatory cytokine (IL-1) might result in different mechanisms of cellular catabolism of the ECM. To test this hypothesis we measured aggrecan loss and cleavage before, during and after subjecting mature bovine cartilage to inflammatory (10 ng/ml of IL-1a) and mechanical (0.2 and 0.5 MPa) stimulations. We found that when stimulated with IL-1 both aggrecanases and MMPs degraded the ECM (aggrecan and collagen) in unloaded and 0.2 MPa loaded cartilage while the 0.5 MPa load was found to completely inhibited the cellular catabolism of the ECM produced by the IL-1 stimulation. Although several studies have reported preventative affects of load on IL-1-induced matrix degradation in isolated chondrocyte systems, to our knowledge this is the first report documenting that mechanical loading of native articular cartilage can inhibit chondrocyte catabolic degradation of the ECM when stimulated by IL-1.
Materials and methods

CHEMICALS
Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO) or Gibco BRL (Grand Island, NY). Culture media (CM) consisted of Dulbecco's Modified Eagle's Medium (DMEM) containing 1% antibiotic/ antimycotic (ABAM), 10 mM HEPES buffer and 50 mg/mL ascorbic acid, used as is or supplemented with 10% fetal bovine serum (FBS) or 1% ITSþ (insulin, human transferrin, and selenous acid, BD Biosciences, Franklin Lakes, NJ) as described below. IL-1a and IL-1b was obtained from R&D Systems (Minneapolis, MN), aggrecanase-1 and MMPs-1, 3 and 13 from Chemicon International (Temecula, CA), and chondroitinase ABC, keratanase and keratanase II from Seikagaku (Tokyo, Japan). Monoclonal antibodies (Mab) AF-28 and BC-3 for aggrecan cleavage sites within the IGD were obtained from Chemicon and Abcam (Cambridge, MA), respectively, and Mab G1, which recognizes the G1 domain within aggrecan, was kindly provided by Dr Peter J. Roughley (Shriners Hospital, McGill University, Montreal, Canada).
TISSUE PREPARATION
Mature bovine knees (young adult 18e24 months old) were obtained from a local abattoir within 24 h postmortem. Seven-millimeter diameter full-thickness (w1.5 mm) cartilage discs (explants) were removed from the underlying bone in the load-bearing regions of the trochlear notch using a biopsy punch and surgical blade. The explants were separated into 24-well plates containing CM þ 10% FBS and incubated at 100% humidity, 5% C0 2 and 95% air at 37 C for 4 days (denoted as days À6 to À2, Fig. 1 ). The media was replaced with CM þ 1% ITS, the explants incubated for another 2 days (days À2 to 0), and the media from the last day (day 0) used to compare the initial 24-hour proteoglycan (PG) loss between the different treatment groups as described below. For specimens analyzed for aggrecan cleavage using Mab the ITSþ was not included in the media to avoid nonspecific cross-reaction with the antibodies. Separate tests found no effect of ITSþ on PG loss in any treatment group (data not shown).
EFFECT OF IL-1a AND IL-1b ON PROTEOGLYCAN LOSS
Preliminary studies were performed to measure the PG loss in cartilage explants exposed to different concentrations of IL-1a and IL-1b over a 6-day period. Explants (N ¼ 5 each treatment) were incubated with IL-1a or IL-1b at concentrations of 0, 0.1, 1, 10 or 100 ng/ml for 6 days. The media was collected at the end of each day with total PG content in the media (days 0e6) and explant (day 6) determined as described below.
MECHANICAL LOADING PROTOCOL
Mechanical loading of the explant was performed using a Mechanical Explant Test System (METS, Fig. 2 ), as previously described 12, 23, 24 . The explants were cyclically loaded with a peak stress of 0.2 or 0.5 MPa (0-topeak, sinusoidal waveform, 0.5 Hz). Four treatment groups (N ¼ 10 explants each) were used: (1) unloaded explants (Control), (2) unloaded explants stimulated with 10 ng/ml of IL-1a (IL-1), (3) loaded explants (Load), and (4) loaded explants stimulated with 10 ng/ml of IL-1a (Load þ IL-1). Stimulation by mechanical load and IL-1a, individually and in combination, was applied for 3 days (stimulation phase) followed by 6 or 3 days of no stimulation (recovery phase) for the 0.2 and 0.5 MPa tests, respectively. Media was exchanged every 24 h for the 0.2 MPa groups and for the 0.5 MPa groups at 1, 3, 6, 9 and 24 h, then every 24 h thereafter.
ANALYSIS OF CELL DEATH
Cell viability was assessed at harvest and each time interval. A w0.5 mm specimen was removed perpendicular to the articular surface, incubated in 60 mM propidium iodide (indicator of cell death) and 10 mM fluorescein diacetate (indicator of cell viability), washed, and imaged using a fluorescent microscope (excitation 488 nm; wavelength's 535 and 630 nm, respectively; Nikon Optiphot-2, Melville, NY) and CCD camera (Optronics, Goleta, CA).
PROTEOGLYCAN AND COLLAGEN LOSS
Each explant was digested at the end of the experiment with papain (1 mg/ml at 65 C for 4 h) and the PG content (sulfated glycosaminoglycans or GAGs) in the explant digest and media determined using the dimethylmethylene blue (DMMB) assay 25 . Likewise collagen content (0.5 MPa only) was determined using the hydroxyproline assay 26 .
ANALYSIS OF ENZYME-GENERATED AGGRECAN FRAGMENTS
In brief, proteoglycans were extracted from the explant and media using 4 M GuHCl in sodium acetate buffer solution, deglycosylated with keratanase (0.001 U/mg GAG), keratanase II (0.001 U/mg GAG) and chondroitinase ABC (0.001 U/mg GAG), and analyzed using Western blots. Western blot analysis was performed using Mab BC-3 for detection of aggrecanase generated aggrecan cleavage at the N-terminal ARGS fragment at the Asn 373 -Ala 374 bond 27 , and Mabs AF-28 and BC-14 were used for detection of MMP mediated cleavage, both of which recognize the N-terminal FFGV fragment at the Asn 341 -Phe 342 bond 28 . As a positive control, purified bovine aggrecan (10 mg/ml) was digested with human recombinant aggrecanase-1 and MMPs-1, 3 and 13, all activated with 1 mM APMA. To ensure that the aggrecan and its catabolites were deglycosylated, Western blot analysis was performed using Mab G1.
STATISTICAL ANALYSIS
For each explant, PG and collagen released to the media were normalized to their total (initial) contents at the start of the experiment (day À1) prior to mechanical and IL-1 stimulation on day 0 (total ¼ digest þ media summed over all times). PG content and PG and collagen losses were averaged for each treatment and plotted as a function of post-treatment time, with the day À1 and day 0 values used to compare baseline (starting) values for each treatment group. Differences between treatment groups were analyzed using the unpaired Student's (two-tailed) t-test and analysis of variance (ANOVA) (Systat, SPSS, Chicago, IL; Excel, Microsoft, Redmond, WA). Turkey/Kramer post-hoc analysis was used to determine statistical differences for temporal responses within each treatment group. All data are expressed as mean AE standard deviation unless otherwise indicated. The statistical significance level (a) was set at 0.05. Fig. 1 . Cartilage specimens were removed from mature bovine knees (day À6) and incubated (Pretreatment) for 5 days (days À6 to À1) in culture media supplemented with 10% FBS (4 days) or 1% ITS (1 day); all media was discarded. The specimens were then separated into four treatment groups (Control, IL-1, Load, Load þ IL-1), incubated in culture media for one additional day (days À1 to 0), and the media sampled (day 0), Treatments began on day 0 (Treatment) and continued for 3 days, with media sampled at 1, 3, 6, 9 and 24 h for the first day and at 24 h intervals thereafter. On day þ3 the treatments were removed (Recovery) and the media sampled on each day. Analyses for PG and collagen content in the media and explant were performed. 
Results
PROTEOGLYCAN LOSS BY IL-1a AND IL-1b IS DOSE AND TIME DEPENDENT
Cartilage explants were incubated over a 6-day period with IL-1a or IL-1b at concentrations of 0, 0.1, 1, 10 or 100 ng/ml and the PG content remaining in each explant normalized by its initial PG content (day À1) (Fig. 3) . For the control groups (no IL-1) the mean PG loss per day was 3.4% AE 2.2% (N ¼ 80, r ¼ 0.842). Both IL-1a and IL1b induced almost identical catabolic responses that were dose and time dependent. At 10 ng/ml the PG loss per day due to IL-1a and IL-1b was 10.6% AE 6.2% (r ¼ 0.869) and 11.3% AE 5.9% (r ¼ 0.891), respectively, not significantly different (P > 0.5). Thus, for the remainder of the experiments we used IL-1a at a concentration of 10 ng/ml.
CELLS REMAIN VIABLE IN RESPONSE TO MECHANICAL LOADING AND IL-1
For each treatment group cell viability was assessed at the end of each experiment using a live/dead cell assay. There was no significant cell death in any treatment group at the time of harvest, on day 0 before the start of the mechanical and IL-1 stimulations, and at the end of each experiment (data not shown). We were thus confident that any PG loss from the explant was due solely to the mechanical or IL-1 stimulations and not cell death.
MECHANICAL LOAD AT 0.2 MPa DID NOT INHIBIT PG LOSS DUE TO IL-1 STIMULATION
Explants were cyclically loaded for 3 days with a stress of 0.2 MPa AE 10 ng/ml of IL-1a and compared to control (no load, no IL-1a) and IL-1a stimulated explants. The PG loss on day 0, 24 h prior to mechanical and IL-1a stimulations, was the same for all treatment groups indicating uniformity of PG loss before application of the mechanical and IL-1a stimulations (Fig. 4) . PG loss in the Control and Load groups were similar on all days (days 0e9). PG loss in the IL-1 group was elevated on all days and the addition of the 0.2 MPa stress did not effect the PG loss caused by exposure to IL-1a. When the load and IL-1a were removed (day 3), the IL-1a stimulated groups (AEload) did not return to the non-IL-1a stimulated PG loss values until day 6 or later.
MECHANICAL LOAD AT 0.5 MPa INHIBITS PG LOSS DUE TO IL-1 STIMULATION
A mechanical load of 0.5 MPa was continuously applied to explants for 3 days (AE10 ng/ml of IL-1a) and the PG loss to the media measured after 1, 3, 6, 9, 24, 48 and 72 h. Thereafter the load and IL-1a stimulations were removed for an additional 3 days (recovery) and the PG loss measured every 24 h. Similar to the 0.2 MPa load, the 0.5 MPa load did not affect the PG loss in non-IL-1a stimulated explants during loading and recovery (Load vs Control, Fig. 5 ).
For the first 9 h of treatment with IL-1a, the PG loss in the IL-1a and Load þ IL-1a groups were not different from the Control and Load groups. Over the next 15 h, however, the PG loss in the IL-1a group significantly increased (P < 0.01; see 24 h, Fig. 5 ) while the addition of the mechanical load inhibited the PG loss (Load þ IL-1a vs IL-1a, 0.1 > P > 0.05), though not to the level of the controls (Load þ IL-1a vs Controls, P < 0.02). For longer incubation times (!24 h), IL-1a stimulation increased the PG loss from 1.6 fold at 24 h to 4.3 and 3.7 fold by days 2 and 3, respectively (IL-1a vs Controls, Fig. 5 ). Application of the 0.5 MPa mechanical load significantly inhibited the IL-1a induced PG loss on days 2 and 3 by 3.1 and 2.3 fold, respectively, however, not to the control levels (Load þ IL-1a vs IL-1a, Fig. 5) .
After removing the load and IL-1a stimulations the PG loss for the IL-1a group decreased by almost 3 fold, returning to the control levels on day 6. However, the PG loss in the Load þ IL-1a group continued to increase (1.9 fold) on day 4 and then slowly decreased over the next 2 days but never reached the control values (P < 0.001, Fig. 5 ). For explants loaded with 0.5 MPa, collagen loss to the media per day (micrograms) was measured in a subset of explants (N ¼ 3 with greatest PG loss) and normalized to the initial collagen content (milligrams, day À1). The collagen loss in the Control and Load groups did not change compared to their baseline loss on day 0 (Fig. 6 ). In the IL-1a group collagen loss did not change for days 1e3 but significantly increased (w100e200 fold) on days 4e6 after IL-1a removal. In the Load þ IL-1a group, the collagen loss did not change during stimulation and 1 day after 
removal of the IL-1a, however, it increased on days 5 and 6 but not to the level of the IL-1a group (47% and 53%, respectively).
MECHANICAL LOADING INHIBITED AGGRECAN CLEAVAGE BY MMPs AND AGGRECANASES
The aggrecan released into the media was analyzed using Western blots to determine the enzyme specific site of aggrecan cleavage. Cleavage within the IGD between G1 and G2 was analyzed using BC-3 Mab to detect aggrecanase generated cleavage and AF-28 and BC-14 Mab to detect MMP cleavage. In addition G1 Mab was used to recognize the G1 domain at the N terminal of the aggrecan.
Two explants were analyzed from each treatment group having similar responses as shown in Figs. 5 and 6, and having the greatest PG loss. The later criteria was chosen to maximize the amount of aggrecan fragmentation for detection of the specific cleavage sites. To further confirm the aggrecan cleavage results from this subset, additional Western blot analyses were performed on a separate set of explants similarly stimulated (0.5 MPa, IL-1a 10 ng/ml) for 3 days plus 1 day of recovery (data not shown). A minimum of two positive specimens out of four analyses were used to validate specificity of aggrecan cleavage sites.
A representative Western blot for all days is shown in Fig. 7 . There were no aggrecan fragments (cleavage products) found in the media of the Control group on any of the Fig. 3 . Cartilage explants were incubated for 24 h in IL-1 free media (days À1 to 0) and then were exposed on day 0 to (a) IL-1a and (b) IL-1b at concentrations of 0, 0.1, 1, 10 and 100 ng/ml for 6 days (days 1e6). The PG content remaining in the explant on each day was determined from the PG released to the media on each day and the PG remaining in the explant on day 6. Media and IL-1 were exchanged on each day. All groups had similar PG contents at the time of IL-1 administration on day 0. The 0 and 10 ng/ml concentrations are highlighted. Data are means AE S.E.M. for n ¼ 5 explants. 100
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days. In the IL-1a treated group, aggrecan fragments where released to the media on days 1e3, when the IL-1a was present within the culture medium, and 1 day after IL-1a removal from the media. Further aggrecan cleavage by either enzyme was not detected (days 5 and 6). The fragments on days 1e4 were generated by aggrecanase and MMP cleavage within the aggrecan's IGD at the Asn 373 -Ala 374 and Asn 341 -Phe 342 sites, respectively. The greatest amount of fragments by both enzymes occurred on day 2.
No aggrecan fragments were found in the media of the Load group on any day nor for the Load þ IL-1a group on days 0e3 (Fig. 7) . However, aggrecan fragments were found in the media of the Load þ IL-1a group 3 day after load and IL-1a removal (day 4). These fragments were generated by aggrecanase and MMP cleavage in about equal amounts.
Aggrecan cleavage (nonspecific) was further confirmed using G1 Mab (Fig. 7) . Aggrecan fragments were found in 24 h without any treatment, exposed on day 0 (Stimulated) to IL-1a (10 ng/ml), Load (0.2 MPa) and Load þ IL-1a for 3 days (days 0e3), and the treatments removed on day 4 (Recovery) for another 6 days (days 4e9). The PG loss to the media per day was normalized to the initial PG content in the explant. All groups had similar initial PG contents at the start of the experiment (day À1, data not shown), and similar PG loss during the 24 h prior to treatment (day 0). Load did not affect the IL-1-induced PG catabolism. Data are means AE S.E.M. for n ¼ 10 explants. 24 h without treatment, exposed on day 0 (0 h) to IL-1a (10 ng/ml), Load (0.5 MPa) and Load þ IL-1a for 3 days (0e72 h), and the treatments removed on day 4 (72 h) for another 3 days (72e144 h). PG loss to the media at each time interval (per hour) was normalized to the initial PG content (day À1). All groups had similar PG loss at the start of the experiment (day 0). Load can now clearly be seen to start inhibiting the IL-1 induced PG catabolism by 24 h, and while still inhibiting the PG catabolism there is a continual increase in the rate of PG loss until the load is removed on day 3. Data are means AE S.E.M. for n ¼ 10 explants.
101 Osteoarthritis and Cartilage Vol. 18, No. 1 the media for the IL-1a group on days 1e5, and the Load and Load þ IL-1a groups on day 4. No aggrecan fragments were detected for the Control group on any day nor for the Load and Load þ IL-1a groups on days 0e3 and 5e6.
Discussion
Previously we used our in vitro METS to produce an OAlike cellular response and ECM damage in mature bovine articular cartilage when loaded with a stress !1 MPa for 24 h 4, 12, 23 . Our METS cyclically loads the ECM in confined compression, a configuration that simulates one aspect of the functional environment within a joint where the compressive stress applied to the articular surface causes fluid (water) and solute transport (i.e., IL-1, aggrecan fragments, nutrients) across the surface. In this study we loaded explants with smaller stresses (0.2e0.5 MPa) for longer times (3 days) and studied the cellular response to these loads individually and when applied simultaneously with an inflammatory cytokine (IL-1). We hypothesized that administration of both stimuli would result in an accelerated was normalized to the initial collagen content (day À1). There was minimal collagen loss in all groups during the treatment interval (Stimulated, days 0e3). After treatment removal (Recovery, days 4e6) there was an increase in collagen loss in the IL-1a group starting on day 4 while in the Load þ IL-1a group an increase in collagen loss was delayed until day 5. Data are means AE S.E.M. for n ¼ 10 explants. Fig. 7 . Aggrecan fragments released into the media before (day 0, D0) and during treatment (days 1e3, D1eD3) and recovery (days 4e6, D4eD6) were measured by Western blot analysis using antibodies which recognize aggrecan cleavage sites within the interglobular (G1eG2) domain (BC-3 and AF-28/BC-14 for aggrecanase and MMP generated cleavage, respectively; G1 recognizes the G1 domain).
No aggrecan fragments were found in the Control group (C) on any day (only D1 is shown). In the Load (L) group the G1 domain fragment was detected only on day 4 (only D4 is shown). In the IL-1a (IL-1) group aggrecan cleavage by both enzymes was detected on days 1e4, with the greatest amount of fragments occurring on day 2. Load inhibited IL-1-induced aggrecan cleavage by both enzymes except on day 4 were both enzyme cleavage sites were detected (L þ IL-1; only D4 is shown).
102 P. A. Torzilli et al.: Load inhibits IL-1 cartilage degradation degradation process. On the contrary, we found that the 0.5 MPa stress inhibited the IL-1-induced cellular catabolism of the ECM while the 0.2 MPa stress had no effect. To our knowledge this is the first study to evaluate the coupled effects of IL-1 and mechanical load on ECM degradation in full-thickness, native, mature articular cartilage. Similar to other studies 3, 5, 29 we found that exposure of unloaded, free-swelling articular cartilage to IL-1 over a 6-day interval resulted in aggrecan cleavage and loss to the media (Figs. 3e5) . Western blot analysis of aggrecan fragments revealed that cleavage within the IGD was at two different sites attributed to aggrecanase and MMP activity (Asn 373 -Ala 374 and Asn 341 -Phe 342 bonds, respectively). Both cleavage-site fragments appeared at equivalent times after IL-1 administration (Fig. 7) , which differs from previous findings in which aggrecan was initially cleaved by aggrecanases and at a later time by MMPs 3,29,30 . While we cannot explain this difference, it is most likely due to differences in specie (bovine vs human), age (immature vs mature), joint (knee vs ankle), tissue type (articular vs nasal), explant geometry (full-thickness vs partial), stimulus interval, and even the test configuration (confined vs unconfined).
Application of a cyclic mechanical load of 0.2 or 0.5 MPa for 3 days did not cause ECM degradation compared to unloaded, free-swelling controls. This result is not unique as similar findings have been reported for loads 0.5 MPa under a variety of different loading regimes (unconfined, intermittent, duration) 31e34 . Based on these and other studies 35, 36 we can hypothesize that a cyclic stress of 0.5 MPa applied to the ECM (equivalent static stress of 0.35 MPa) is probably below the level needed to cause a significant catabolic response by the chondrocytes. However, this hypothesis needs to be validated especially considering the inhomogeneous and anisotropic properties of the ECM where local deformations are significantly greater at the articular surface then in the deeper zones 36, 37 . One of the most interesting findings of our study was that a 0.2 MPa cyclic stress applied concurrently with IL-1a (10 ng/ml) had no effect on ECM degradation while a 0.5 MPa stress significantly inhibited the IL-1a-induced ECM degradation. Similar to our lower stress, Shin et al. 38 reported that IL-1-induced (1 ng/ml) PG loss in meniscal fibrocartilage explants was not inhibited by cyclic compression (0.1 MPa, 0.5 Hz, 24 h). On the contrary, our higher stress almost completely inhibited the increased PG loss caused by the IL-1 stimulation (Fig. 5) while completely inhibiting aggrecan cleavage within the IGD as no fragments were found in the media until after load removal on day 4 (Fig. 6) . The absence of aggrecan cleavage products within the ECM was later confirmed by Western blot analyses (data not shown). This unique finding has not been previously reported and indicates that mechanical loads >0.2 MPa applied to native articular cartilage may have an anti-inflammatory role in counteracting the degradative affects of IL-1. At present the exact mechanism for the inhibition is not known but probably involves preservation of the mechanobiological signal-transduction pathways between the ECM and the chondrocyte.
Several other studies have reported similar inhibitory affects of a mechanical stimulus on chondrocyte response to IL-1 (10 ng/ml) stimulation. However different from our METS configuration which applied a cyclic load (stress) to native cartilage in confined compression, these studies applied a cyclic deformation (strain) to isolated chondrocytes (monolayer tensile) or to chondrocyte-seeded agarose gels (unconfined compression). While different these cellbased configurations can help explain possible inhibitory mechanisms when loading intact cartilage using our METS. Agarwal et al. 16,19e21,39 reported that tensile strain (3%, 20%) inhibited or reduced IL-1-induced increases in gene expression (mRNA) for nitric oxide (NO), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-a, cyclo-oxygenase (COX)-2, and MMP-3, 7, 8, 9, 13, 16, 17 and 19, had no affect on MMP-2, 11 and 14 and Tissue Inhibitor of Metalloprotinease-1, 2 and 3 (TIMPs), and reversed IL-1 inhibition of aggrecan synthesis. They concluded that the tensile strain acts at multiple sites within the NF-kB signaling pathway. Likewise, Chowdbury et al. 17, 18, 40 found a compressive strain (15%) inhibited IL-1-induced increases in synthesis of NO and prostaglandin-E2 and mRNA for iNOS and COX-2, and that the mechanical affect involved the p38 mitogen-activated protein kinase (MAPK) dependent pathway. Contrary to these inhibitory effects, Lima et al. 41 reported that a compressive strain (10% AE 5%) did not counteract the catabolic effects of IL-1-induced loss of GAG content and mechanical properties in long-term ( 45 days) chondrocyte-gel cultures. However, this result was confounded by the presence in the culture media of dexamethasone (0.1 mM) and transforming growth factor-beta (TGF-b) (10 ng/ml), two cytokines that can be mutually antagonistic, regulate the gene expression for MMPs, and inhibit IL-1-induced ECM degradation 42e46 . In either case, these results indicate that under a variety of loading conditions and configurations, a mechanical stimulus of sufficient magnitude and duration can counteract the IL-1-induced catabolic degradation of the cartilage ECM.
Once the load and IL-1a stimulations were removed (recovery >72 h) the ECM degradation was found to increase dramatically for the next 24 h (96 h, Fig. 5 ; day 4, Fig. 7 ) and then gradually decrease over the next 48 h (120 and 144 h, Fig. 5 ). What caused the large increase in PG release after the load and IL-1a were removed is not known. Several mechanisms are possible: a cellular catabolic response due to the removal of the load and IL1a; residual IL-1a in the ECM after load removal; release of trapped aggrecan fragments within the compressed ECM; or continued catabolism from the previous 3 days. It is unlikely that a catabolic response resulted from the simultaneous removal of both stimuli since a similar response was not observed in the Load or IL-1 groups. On the other hand, aggrecan entrapment within the ECM probably occurred during cyclic loading as we have previously reported on this mechanism 47 Even though aggrecan entrapment may have occurred in both loaded groups, it can only partially explain the increase in aggrecan release in the Load þ IL-1 group since this did not occur in the Load group (Fig. 5) . In addition, only intact aggrecan was released to the media during loading in both groups while aggrecan fragments were released only in the Load þ IL-1 group on day 4 (Fig. 7) . Finally aggrecan fragments were not found within the ECM of any group on day 3, thus ruling out fragment entrapment (Western blot analysis; data not shown).
The most likely mechanism responsible for the increased aggrecan release after both stimuli were removed appears to be from residual IL-1a in the ECM. Since aggrecan release in the IL-1 group significantly decreased after IL-1a removal, it may be that the concentration of residual IL-1a in the Load þ IL-1 group was greater than in the IL-1 group, causing continued aggrecan degradation. However, a delayed or inhibited cellular response cannot be ruled out.
Concomitant with aggrecan proteolysis in the later stages of degeneration is collagen cleavage by collagenases (MMP-1 and 13). 3, 29, 30, 48, 49 Similar to others we found adelay in collagen loss (days 4e6) in response to IL-1 stimulation (Fig. 6) . On the other hand, the mechanical load did not affect the collagen loss during or after stimulation nor during stimulation when combined with IL-1. Similar to the aggrecan loss, we found increased collagen loss after both stimuli were removed but delayed 1 day (day 5) compared to the aggrecan loss (day 4). Whether the mechanical load inhibited the catabolism of the collagen during loading cannot be assessed, however, it does appear that the loading did delay the collagen loss.
In summary, we examined the effect of mechanical load on the degradation of the ECM by IL-1 and found that a 0.2 MPa stress had no effect while 0.5 MPa almost completely inhibited the IL-1-induced degradation during loading. The mechanism responsible for the inhibition appears to be at the cellular level from an as yet unknown mechanochemical signal-transduction pathway. Further studies will be required to fully understand how different magnitudes, durations and patterns of mechanical load affect cartilage health and degradation in the presence of inflammatory cytokines such as IL-1 and TNF-a.
